Citation: P. Heering et al., INFLUENCE OF THE RENIN-ANGIOTENSIN SYSTEM AND ATRIAL-NATRIURETIC-PEPTIDE ON RENAL FUNCTIONAL RESERVE, Nephron, 66(1), 1994, pp. 14-20
Authors:
HEERING P
SCHADEWALDT P
BACH D
GRABENSEE B
Citation: P. Heering et al., NEPHROTOXICITY OF CYCLOSPORINE IN HUMANS - EFFECT OF CYCLOSPORINE ON GLOMERULAR-FILTRATION AND PROXIMAL TUBULAR REABSORPTION, The Clinical investigator, 71(12), 1993, pp. 1010-1015
Citation: K. Ivens et al., CYCLOSPORINE IN THE TREATMENT OF NEPHROTI C SYNDROME IN PRIMARY GLOMERULONEPHRITIS - APPLICATION, Nieren- und Hochdruckkrankheiten, 22, 1993, pp. 190000018-190000023
Authors:
HEERING P
WYES D
PLUM J
GRABENSEE B
HEINE H
Citation: P. Heering et al., INFLUENCE OF THE RENIN-ANGIOTENSIN SYSTEM (RAS) ON RENAL FUNCTIONAL RESERVE (RFR), Kidney international, 44(1), 1993, pp. 239-239
Authors:
BRAUN N
PRZECHERA M
WEBER A
MULLER GA
ERLEY C
HEERING P
ZAUNER I
GRUPP C
FUNFSTUCK R
FRANZ HE
SCHOLLMEYER P
GRABENSEE B
STEIN G
RISLER T
Citation: N. Braun et al., THERAPY OF THE MEMBRANOUS GLOMERULONEPHRITIS WITH NEPHROTIC SYNDROME - A PROSPECTIVE, RANDOMIZED MULTICENTER STUDY, Kidney international, 44(1), 1993, pp. 249-250
Citation: P. Heering et B. Grabensee, IS THE CREATININE CLEARANCE A MARKER FOR GFR IN RENAL GRAFT RECIPIENTS TREATED WITH CYCLOSPORINE (CSA), Kidney international, 44(1), 1993, pp. 255-255
Authors:
WESTHOFF A
HEERING P
IVENS K
KOCH M
GRABENSEE B
Citation: A. Westhoff et al., CYCLOSPORINE OR AZATHIOPRINE FOLLOWING TRIPLE THERAPY - A PROSPECTIVERANDOMIZED STUDY, Kidney international, 44(1), 1993, pp. 255-255